financetom
Business
financetom
/
Business
/
Sonos Insider Sold Shares Worth $429,375, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sonos Insider Sold Shares Worth $429,375, According to a Recent SEC Filing
Aug 22, 2024 2:06 AM

04:22 PM EDT, 08/21/2024 (MT Newswires) -- Maxime Bouvat-Merlin, Chief Product Officer, on August 19, 2024, sold 37,256 shares in Sonos ( SONO ) for $429,375.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1314727/000112760224022707/xslF345X05/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
World Health Organization Adds Ozempic, Mounjaro to Essential Medicines List
World Health Organization Adds Ozempic, Mounjaro to Essential Medicines List
Sep 5, 2025
10:08 AM EDT, 09/05/2025 (MT Newswires) -- The World Health Organization said Friday it has added Novo Nordisk's ( NVO ) Ozempic and Eli Lilly's ( LLY ) Mounjaro to its list of essential medicines. The list, which includes drugs for priority health needs of populations, is used in more than 150 countries as a basis for public-sector procurement, medicine...
Market Chatter: Carney To Pause 2026 EV Target, Announce New Tariff Supports
Market Chatter: Carney To Pause 2026 EV Target, Announce New Tariff Supports
Sep 5, 2025
09:57 AM EDT, 09/05/2025 (MT Newswires) -- Prime Minister Mark Carney is set to announce a nine-part strategy to support sectors impacted by U.S. President Donald Trump's tariffs, which will include a review of the federal government's electric vehicle (EV) mandate, CTV News has learned on Friday. It noted Carney is scheduled to make the announcement on Friday in Mississauga,...
Mineralys Says Lorundrostat Shows 'Meaningful' Blood Pressure Reductions in Phase 3 Trial
Mineralys Says Lorundrostat Shows 'Meaningful' Blood Pressure Reductions in Phase 3 Trial
Sep 5, 2025
09:50 AM EDT, 09/05/2025 (MT Newswires) -- Mineralys Therapeutics ( MLYS ) said Friday that new analysis from its phase 3 trial evaluating lorundrostat in uncontrolled or resistant hypertension showed statistically significant and clinically meaningful reductions in blood pressure compared with placebo. The study, which enrolled 1,083 participants, also showed favorable safety and tolerability outcomes across all groups in the...
AltaGas Closes $200 Million Hybrid Note Offering
AltaGas Closes $200 Million Hybrid Note Offering
Sep 5, 2025
09:52 AM EDT, 09/05/2025 (MT Newswires) -- AltaGas ( ATGFF ) Friday closed its previously announced offering of $200 million of 5.375% Fixed-to-Fixed Rate Junior Subordinated Notes, Series 4 due Dec. 5, 2055. Proceeds of the offering will be used to redeem or buy back its outstanding Cumulative Redeemable 5-Year Rate Reset Preferred Shares, Series A and Cumulative Redeemable Floating...
Copyright 2023-2026 - www.financetom.com All Rights Reserved